Kinarus Therapeutics Holding AG
SIX:KNRS
Income Statement
Earnings Waterfall
Kinarus Therapeutics Holding AG
Revenue
|
0
CHF
|
Operating Expenses
|
-13.9m
CHF
|
Operating Income
|
-13.9m
CHF
|
Other Expenses
|
-6k
CHF
|
Net Income
|
-13.9m
CHF
|
Income Statement
Kinarus Therapeutics Holding AG
Jun-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|
Revenue | |||||||
Revenue |
4
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
Gross Profit | |||||||
Cost of Revenue |
(4)
|
0
|
0
|
0
|
0
|
0
|
|
Gross Profit |
1
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
Operating Income | |||||||
Operating Expenses |
(1)
|
(0)
|
(1)
|
(2)
|
(3)
|
(14)
|
|
Selling, General & Administrative |
(1)
|
(0)
|
(1)
|
(41)
|
(42)
|
(14)
|
|
Research & Development |
0
|
0
|
(0)
|
(2)
|
(2)
|
0
|
|
Depreciation & Amortization |
(0)
|
0
|
(0)
|
(2)
|
(2)
|
0
|
|
Other Operating Expenses |
0
|
0
|
0
|
41
|
41
|
(0)
|
|
Operating Income |
(1)
N/A
|
(0)
+48%
|
(1)
-179%
|
(2)
-110%
|
(3)
-40%
|
(14)
-312%
|
|
Pre-Tax Income | |||||||
Interest Income Expense |
1
|
0
|
0
|
(0)
|
(0)
|
(0)
|
|
Non-Reccuring Items |
(1)
|
0
|
0
|
(38)
|
(38)
|
0
|
|
Pre-Tax Income |
0
N/A
|
(0)
N/A
|
(1)
-617%
|
(41)
-3 855%
|
(42)
-3%
|
(14)
+67%
|
|
Net Income | |||||||
Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
|
Income from Continuing Operations |
0
|
(0)
|
(1)
|
(41)
|
(42)
|
(14)
|
|
Income to Minority Interest |
0
|
0
|
0
|
0
|
(0)
|
0
|
|
Net Income (Common) |
0
N/A
|
(0)
N/A
|
(1)
-579%
|
(41)
-4 079%
|
(42)
-3%
|
(14)
+67%
|
|
EPS (Diluted) |
0
N/A
|
0
N/A
|
0
N/A
|
-0.04
N/A
|
-0.04
N/A
|
-0.01
+75%
|